Two new painkillers

Two ingenious drugs have been added to the opioid armamentarium.

The place of opioids in the management of chronic non-cancer pain is limited, compared with its role in the management of severe acute pain and malignant pain, and in palliative care in non-cancer conditions.

Brain scan

Morphine, oxycodone, fentanyl, methadone, buprenorphine and hydromorphone are traditional WHO step III opioid analgesics used as a mainstay in the treatment of moderate to severe pain.1

These agents should only be considered after trialling or considering other conservative measures, such as the use of step I agents, that is, paracetamol, NSAIDs, adjuvants